Development of heparinized and hepatocyte growth factor‐coated acellular scaffolds using porcine carotid arteries
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2024
DOI: 10.1002/jbm.b.35317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2024. Verfasst von Jin Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Tissue Scaffolds, Hepatocyte Growth Factor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University.
Abstract (Originalsprache)
Tissue‐engineered blood vessel substitutes have been developed due to the lack of suitable small‐diameter vascular grafts. Xenogeneic extracellular matrix (ECM) scaffolds have the potential to provide an ideal source for off‐the‐shelf vascular grafts. In this study, porcine carotid arteries were used to develop ECM scaffolds by decellularization and coating with heparin and hepatocyte growth factor (HGF). After decellularization, cellular and nucleic materials were successfully removed with preservation of the main compositions (collagen, elastin, and basement membrane) of the native ECM. The ultimate tensile strength, suture strength, and burst pressure were significantly increased after cross‐linking. Pore size distribution analysis revealed a porous structure within ECM scaffolds with a high distribution of pores larger than 10 μm. Heparinized scaffolds exhibited sustained release of heparin in vitro and showed potent anticoagulant activity by prolonging activated partial thromboplastin time. The scaffolds showed an enhanced HGF binding capacity as well as a constant release of HGF as a result of heparin modification. When implanted subcutaneously in rats, the modified scaffolds revealed good biocompatibility with enzyme degradation resistance, mitigated immune response, and anti‐calcification. In conclusion, heparinized and HGF‐coated acellular porcine carotid arteries may be a promising biological scaffold for tissue‐engineered vascular grafts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China.
ORCID-Profile: Yongquan Gu
Förderung
- National Key Research and Development Program of China
- Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University
Zitieren
APA
Cheng, J., Wang, C., Guo, L., & Gu, Y. (2024). Development of heparinized and hepatocyte growth factor‐coated acellular scaffolds using porcine carotid arteries. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.35317
Vancouver
Cheng J, Wang C, Guo L, Gu Y. Development of heparinized and hepatocyte growth factor‐coated acellular scaffolds using porcine carotid arteries. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2024. doi:10.1002/jbm.b.35317
BibTeX
@article{Cheng2024,
author = {Cheng, Jin and Wang, Cong and Guo, Lianrui and Gu, Yongquan},
title = {Development of heparinized and hepatocyte growth factor‐coated acellular scaffolds using porcine carotid arteries},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2024},
doi = {10.1002/jbm.b.35317}
}
EUVIMED